"Not only that, but the structure we observed matches the known structure of lysozyme and shows no significant sign of radiation damage, despite the fact that the pulses completely destroy the sample. This is the first high-resolution demonstration of the 'diffraction-before-destruction' technique on biological samples, where we're able to measure a sample before the powerful pulses of the LCLS damage it," he added.
The team chose lysozyme as the first sample for their research because it is easy to crystallize and has been extensively studied. Their work not only determined lysozyme's structure at such high resolution that it showed individual amino acids, but also proved the ability to use extremely small crystals for a range of applications. Boutet says the team has also studied more complex proteins and systems that they are analyzing now.
Ultimately, scientists using LCLS are driving toward an atomic- and molecular-scale understanding of complex biological systems -- such as the membrane proteins that are critical in cell functions and the mechanisms that power photosynthesis -- which could lead to discoveries in a range of sciences, from pharmaceutical breakthroughs to new sources of alternative energy.
The experiment was the first study performed on the new Coherent X-ray Imaging (CXI) instrument, a "molecular camera" designed, built and commissioned by SLAC and now available to the scientific community. Also key to the study was a novel custom-made detector, the Cornell-SLAC Pixel Array Detector (CSPAD), developed in collaboration between Cornell University and SLAC for use at the CXI instrument.
"This important demonstration shows that the technique works, and it paves the way for a lot of exciting experiments to come," says Boutet.